Neurotrophin-3 stimulates migration of mesenchymal stem cells overexpressing TrkC

Current Medicinal Chemistry

Volumn 20, Issue 24, 2013, Pages 3022-3033

  Chen, Y F ^a   Zeng, X ^b   Zhang, K ^a   Lai, B Q ^b   LaiLing, E A ^c   Zeng, Y S ^a,b,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Bone marrow mesenchymal stem cells; Cell therapy; Cell transplantation; Chemokine; Chemotaxis; Neurotrophin 3; Spinal cord injury; Tyrosine kinase C

Indexed keywords

ADENOVIRUS VECTOR; GELATIN SPONGE; NEUROTROPHIN 3; NEUROTROPHIN 3 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL STIMULATION; CELL TRACKING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INFLAMMATION; MESENCHYMAL STEM CELL; MICROPIPETTE; MICROSCOPY; NONHUMAN; RAT; SPINAL CORD; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL MOVEMENT; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NEUROTROPHIN 3; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKC; SPINAL CORD INJURIES;

EID: 84880257871     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320240007     Document Type: Article

References (66)

1. Hugenholtz, H.; Cass, D.E.; Dvorak, M.F.; Fewer, D.H.; Fox, R.J.; Izukawa, D.M.; Lexchin, J.; Tuli, S.; Bharatwal, N.; Short, C., High-dose methylprednisolone for acute closed spinal cord injury-only a treatment option. Can. J. Neurol. Sci., 2002, 29(3), 227-235.
2. Lima, C.; Escada, P.; Pratas-Vital, J.; Branco, C.; Arcangeli, C.A.; Lazzeri, G.; Maia, C.A.; Capucho, C.; Hasse-Ferreira, A.; Peduzzi, J.D., Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabil Neural Repair, 2010, 24(1), 10-22.
3. Mackay-Sim, A.; Feron, F.; Cochrane, J.; Bassingthwaighte, L.; Bayliss, C.; Davies, W.; Fronek, P.; Gray, C.; Kerr, G.; Licina, P.; Nowitzke, A.; Perry, C.; Silburn, P.A.; Urquhart, S.; Geraghty, T., Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain, 2008, 131, (Pt 9), 2376-2386.
4. Huang, H.; Chen, L.; Wang, H.; Xiu, B.; Li, B.; Wang, R.; Zhang, J.; Zhang, F.; Gu, Z.; Li, Y.; Song, Y.; Hao, W.; Pang, S.; Sun, J., Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin. Med. J. (Engl)., 2003, 116(10), 1488-1491.
5. Huang, H.; Wang, H.; Chen, L.; Gu, Z.; Zhang, J.; Zhang, F.; Song, Y.; Li, Y.; Tan, K.; Liu, Y.; Xi, H., Influence factors for functional improvement after olfactory ensheathing cell transplantation for chronic spinal cord injury. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2006, 20(4), 434-438.
6. Lima, C.; Pratas-Vital, J.; Escada, P.; Hasse-Ferreira, A.; Capucho, C.; Peduzzi, J.D., Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study. J. Spinal. Cord. Med., 2006, 29(3), 191-203, discussion 204-196.
7. Geffner, L.F.; Santacruz, P.; Izurieta, M.; Flor, L.; Maldonado, B.; Auad, A.H.; Montenegro, X.; Gonzalez, R.; Silva, F., Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant, 2008, 17(12), 1277-1293.
8. Yoon, S.H.; Shim, Y.S.; Park, Y.H.; Chung, J.K.; Nam, J.H.; Kim, M.O.; Park, H.C.; Park, S.R.; Min, B.H.; Kim, E.Y.; Choi, B.H.; Park, H.; Ha, Y., Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells, 2007, 25(8), 2066-2073.
9. Kang, K.S.; Kim, S.W.; Oh, Y.H.; Yu, J.W.; Kim, K.Y.; Park, H.K.; Song, C.H.; Han, H., A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy, 2005, 7(4), 368-373.
10. Sykova, E.; Homola, A.; Mazanec, R.; Lachmann, H.; Konradova, S.L.; Kobylka, P.; Padr, R.; Neuwirth, J.; Komrska, V.; Vavra, V.; Stulik, J.; Bojar, M., Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant, 2006, 15(8-9), 675-687.
11. Pal, R.; Venkataramana, N.K.; Bansal, A.; Balaraju, S.; Jan, M.; Chandra, R.; Dixit, A.; Rauthan, A.; Murgod, U.; Totey, S., Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy, 2009, 11(7), 897-911.
12. Sykova, E.; Jendelova, P.; Urdzikova, L.; Lesny, P.; Hejcl, A., Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Cell. Mol. Neurobiol., 2006, 26(7-8), 1113-1129.
13. Park, J.H.; Kim, D.Y.; Sung, I.Y.; Choi, G.H.; Jeon, M.H.; Kim, K.K.; Jeon, S.R., Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery, 2012, 70(5), 1238-1247; discussion 1247.
14. Zhang, W.; Zeng, Y.S.; Zhang, X.B.; Wang, J.M.; Chen, S.J., Combination of adenoviral vector-mediated neurotrophin-3 gene transfer and retinoic acid promotes adult bone marrow cells to differentiate into neuronal phenotypes. Neurosci. Lett., 2006, 408(2), 98-103.
15. Zhang, Y.Q.; He, L.M.; Xing, B.; Zeng, X.; Zeng, C.G.; Zhang, W.; Quan, D.P.; Zeng, Y.S., Neurotrophin-3 gene-modified Schwann cells promote TrkC gene-modified mesenchymal stem cells to differentiate into neuron-like cells in poly(lactic-Acid-coglycolic acid) multiple-channel conduit. Cells. Tissues. Organs., 2012, 195(4), 313-322.
16. Ding, Y.; Yan, Q.; Ruan, J.W.; Zhang, Y.Q.; Li, W.J.; Zeng, X.; Huang, S.F.; Zhang, Y.J.; Wu, J.L.; Fisher, D.; Dong, H.; Zenga, Y.S., Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Overexpressing TrkC into Neuron-Like Cells in Transected Spinal Cord of Rats. Cell Transplant, 2012.
17. Qian, L.; Saltzman, W.M., Improving the expansion and neuronal differentiation of mesenchymal stem cells through culture surface modification. Biomaterials, 2004, 25(7-8), 1331-1337.
18. Lescaudron, L.; Naveilhan, P.; Neveu, I., The use of stem cells in regenerative medicine for Parkinson's and Huntington's diseases. Curr. Med. Chem., 2012, 19(35), 6018-6035.
19. Borlongan, C.V.; Fournier, C.; Stahl, C.E.; Yu, G.; Xu, L.; Matsukawa, N.; Newman, M.; Yasuhara, T.; Hara, K.; Hess, D.C.; Sanberg, P.R., Gene therapy, cell transplantation and stroke. Front. Biosci., 2006, 11, 1090-1101.
20. Laird, D.J.; von Andrian, U.H.; Wagers, A.J., Stem cell trafficking in tissue development, growth, and disease. Cell, 2008, 132(4), 612-630.
21. Smart, N.; Riley, P.R., The stem cell movement. Circ. Res., 2008, 102(10), 1155-1168.
22. Krankel, N.; Spinetti, G.; Amadesi, S.; Madeddu, P., Targeting stem cell niches and trafficking for cardiovascular therapy. Pharmacol. Ther., 2011, 129(1), 62-81.
23. Wang, C.H.; Cherng, W.J.; Yang, N.I.; Kuo, L.T.; Hsu, C.M.; Yeh, H.I.; Lan, Y.J.; Yeh, C.H.; Stanford, W.L., Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb. Vasc. Biol., 2008, 28(1), 54-60.
24. Mauney, J.; Olsen, B.R.; Volloch, V., Matrix remodeling as stem cell recruitment event: a novel in vitro model for homing of human bone marrow stromal cells to the site of injury shows crucial role of extracellular collagen matrix. Matrix. Biol., 2010, 29(8), 657-663.
25. Haider, H.; Jiang, S.; Idris, N.M.; Ashraf, M., IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair. Circ. Res., 2008, 103(11), 1300-1308.
26. Wojakowski, W.; Kucia, M.; Kazmierski, M.; Ratajczak, M.Z.; Tendera, M., Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism? Heart, 2008, 94(1), 27-33.
27. Chen, F.M.; Ma, Z.W.; Wang, Q.T.; Wu, Z.F., Gene delivery for periodontal tissue engineering: current knowledge -future possibilities. Curr. Gene. Ther., 2009, 9(4), 248-266.
28. Seidel, J.; Niggemann, B.; Punzel, M.; Fischer, J.; Zanker, K.S.; Dittmar, T., The neurotransmitter GABA is a potent inhibitor of the stromal cell-derived factor-1alpha induced migration of adult CD133+ hematopoietic stem and progenitor cells. Stem. Cells. Dev., 2007, 16(5), 827-836.
29. Chao, M.V.; Rajagopal, R.; Lee, F.S., Neurotrophin signalling in health and disease. Clin. Sci. (Lond)., 2006, 110(2), 167-173.
30. Bibel, M.; Barde, Y.A., Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes. Dev., 2000, 14(23), 2919-2937.
31. Blesch, A.; Lu, P.; Tuszynski, M.H., Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain. Res. Bull., 2002, 57(6), 833-838.
32. De Simone, R.; Ambrosini, E.; Carnevale, D.; Ajmone-Cat, M.A.; Minghetti, L., NGF promotes microglial migration through the activation of its high affinity receptor: modulation by TGF-beta. J. Neuroimmunol., 2007, 190(1-2), 53-60.
33. Rahbek, U.L.; Dissing, S.; Thomassen, C.; Hansen, A.J.; Tritsaris, K., Nerve growth factor activates aorta endothelial cells causing PI3K/Akt-And ERK-dependent migration. Pflugers. Arch., 2005, 450(5), 355-361.
34. Chiaramello, S.; Dalmasso, G.; Bezin, L.; Marcel, D.; Jourdan, F.; Peretto, P.; Fasolo, A.; De Marchis, S., BDNF/TrkB interaction regulates migration of SVZ precursor cells via PI3-K and MAP-K signalling pathways. Eur. J. Neurosci., 2007, 26(7), 1780-1790.
35. Zhang, Y.Q.; Zeng, X.; He, L.M.; Ding, Y.; Li, Y.; Zeng, Y.S., NT-3 gene modified Schwann cells promote TrkC gene modified mesenchymal stem cells to differentiate into neuron-like cells in vitro. Anat. Sci. Int., 2010, 85(2), 61-67.
36. Wang, J.M.; Zeng, Y.S.; Liu, R.Y.; Huang, W.L.; Xiong, Y.; Wang, Y.H.; Chen, S.J.; Teng, Y.D., Recombinant adenovirus vector-mediated functional expression of neurotropin-3 receptor (TrkC) in neural stem cells. Exp. Neurol., 2007, 203(1), 123-127.
37. Zhang, Y.; Dijkhuizen, P.A.; Anderson, P.N.; Lieberman, A.R.; Verhaagen, J., NT-3 delivered by an adenoviral vector induces injured dorsal root axons to regenerate into the spinal cord of adult rats. J. Neurosci. Res., 1998, 54(4), 554-562.
38. Zeng, X.; Zeng, Y.S.; Ma, Y.H.; Lu, L.Y.; Du, B.L.; Zhang, W.; Li, Y.; Chan, W.Y., Bone Marrow Mesenchymal Stem Cells in a Three Dimensional Gelatin Sponge Scaffold Attenuate Inflammation, Promote Angiogenesis and Reduce Cavity Formation in Experimental Spinal Cord Injury. Cell Transplant, 2011, 20(11-12), 1881-1899.
39. Scuri, M.; Samsell, L.; Piedimonte, G., The role of neurotrophins in inflammation and allergy. Inflamm Allergy Drug Targets, 2010, 9(3), 173-180.
40. Tzeng, S.F.; Huang, H.Y.; Lee, T.I.; Jwo, J.K., Inhibition of lipopolysaccharide-induced microglial activation by preexposure to neurotrophin-3. J. Neurosci. Res., 2005, 81(5), 666-676.
41. Reinshagen, M.; Rohm, H.; Steinkamp, M.; Lieb, K.; Geerling, I.; Von Herbay, A.; Flamig, G.; Eysselein, V.E.; Adler, G., Protective role of neurotrophins in experimental inflammation of the rat gut. Gastroenterology, 2000, 119(2), 368-376.
42. Von Luttichau, I.; Notohamiprodjo, M.; Wechselberger, A.; Peters, C.; Henger, A.; Seliger, C.; Djafarzadeh, R.; Huss, R.; Nelson, P.J., Human adult CD34-progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem. Cells. Dev., 2005, 14(3), 329-336.
43. Honczarenko, M.; Le, Y.; Swierkowski, M.; Ghiran, I.; Glodek, A.M.; Silberstein, L.E., Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells, 2006, 24(4), 1030-1041.
44. Sordi, V.; Malosio, M.L.; Marchesi, F.; Mercalli, A.; Melzi, R.; Giordano, T.; Belmonte, N.; Ferrari, G.; Leone, B.E.; Bertuzzi, F.; Zerbini, G.; Allavena, P.; Bonifacio, E.; Piemonti, L., Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood, 2005, 106(2), 419-427.
45. Son, B.R.; Marquez-Curtis, L.A.; Kucia, M.; Wysoczynski, M.; Turner, A.R.; Ratajczak, J.; Ratajczak, M.Z.; Janowska-Wieczorek, A., Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells, 2006, 24(5), 1254-1264.
46. Ji, J.F.; He, B.P.; Dheen, S.T.; Tay, S.S., Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells, 2004, 22(3), 415-427.
47. Ponte, A.L.; Marais, E.; Gallay, N.; Langonne, A.; Delorme, B.; Herault, O.; Charbord, P.; Domenech, J., The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells, 2007, 25(7), 1737-1745.
48. Wang, L.; Li, Y.; Chen, X.; Chen, J.; Gautam, S.C.; Xu, Y.; Chopp, M., MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology, 2002, 7(2), 113-117.
49. Binger, T.; Stich, S.; Andreas, K.; Kaps, C.; Sezer, O.; Notter, M.; Sittinger, M.; Ringe, J., Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp. Cell. Res., 2009, 315(8), 1468-1479.
50. Hohensinner, P.J.; Kaun, C.; Rychli, K.; Niessner, A.; Pfaffenberger, S.; Rega, G.; Furnkranz, A.; Uhrin, P.; Zaujec, J.; Afonyushkin, T.; Bochkov, V.N.; Maurer, G.; Huber, K.; Wojta, J., The inflammatory mediator oncostatin M induces stromal derived factor-1 in human adult cardiac cells. FASEB J, 2009, 23(3), 774-782.
51. Zicha, D.; Dunn, G.A., Are growth factors chemotactic agents? Exp. Cell. Res., 1995, 221(2), 526-529.
52. Devreotes, P.N.; Zigmond, S.H., Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium. Annu. Rev. Cell. Biol., 1988, 4, 649-686.
53. Wessels, D.; Vawter-Hugart, H.; Murray, J.; Soll, D.R., Threedimensional dynamics of pseudopod formation and the regulation of turning during the motility cycle of Dictyostelium. Cell Motil Cytoskeleton, 1994, 27(1), 1-12.
54. Yang, Z.; Duan, H.; Mo, L.; Qiao, H.; Li, X., The effect of the dosage of NT-3/chitosan carriers on the proliferation and differentiation of neural stem cells. Biomaterials, 2010, 31(18), 4846-4854.
55. Goncalves, M.; Castro, R.; Rodrigues, J.; Tomas, H., The effect of PAMAM dendrimers on mesenchymal stem cell viability and differentiation. Curr. Med. Chem., 2012, 19(29), 4969-4975.
56. Pavlova, G.; Lopatina, T.; Kalinina, N.; Rybalkina, E.; Parfyonova, Y.; Tkachuk, V.; Revishchin, A., In vitro neuronal induction of adipose-derived stem cells and their fate after transplantation into injured mouse brain. Curr. Med. Chem., 2012, 19(30), 5170-5177.
57. Lai, B.Q.; Wang, J.M.; Duan, J.J.; Chen, Y.F.; Gu, H.Y.; Ling, E.A.; Wu, J.L.; Zeng, Y.S., The integration of NSC-derived and host neural networks after rat spinal cord transection. Biomaterials, 2013, 34(12), 2888-2901.
58. Donovan, M.J.; Miranda, R.C.; Kraemer, R.; McCaffrey, T.A.; Tessarollo, L.; Mahadeo, D.; Sharif, S.; Kaplan, D.R.; Tsoulfas, P.; Parada, L.; et al., Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. Am. J. Pathol., 1995, 147(2), 309-324.
59. Yamauchi, J.; Chan, J.R.; Shooter, E.M., Neurotrophin 3 activation of TrkC induces Schwann cell migration through the c-Jun Nterminal kinase pathway. Proc. Natl. Acad. Sci. U S A., 2003, 100(24), 14421-14426.
60. Saini, H.S.; Gorse, K.M.; Boxer, L.M.; Sato-Bigbee, C., Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells. J. Neurochem., 2004, 89(4), 951-961.
61. McTigue, D.M.; Horner, P.J.; Stokes, B.T.; Gage, F.H., Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci., 1998, 18(14), 5354-5365.
62. Liu, Z.; Ding, Y.; Zeng, Y.S., A new combined therapeutic strategy of governor vessel electro-Acupuncture and adult stem cell transplantation promotes the recovery of injured spinal cord. Curr. Med. Chem., 2011, 18(33), 5165-5171.
63. Ivanov, S.V.; Panaccione, A.; Brown, B.; Guo, Y.; Moskaluk, C.A.; Wick, M.J.; Brown, J.L.; Ivanova, A.V.; Issaeva, N.; El-Naggar, A.K.; Yarbrough, W.G., TrkC signaling is activated in adenoid cystic carcinoma and requires NT-3 to stimulate invasive behavior. Oncogene, 2012, Oct 1,[Epub ahead of print].
64. Truzzi, F.; Marconi, A.; Lotti, R.; Dallaglio, K.; French, L.E.; Hempstead, B.L.; Pincelli, C., Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J. Invest. Dermatol., 2008, 128(8), 2031-2040.
65. Shonukan, O.; Bagayogo, I.; McCrea, P.; Chao, M.; Hempstead, B., Neurotrophin-induced melanoma cell migration is mediated through the actin-bundling protein fascin. Oncogene, 2003, 22(23), 3616-3623.
66. Lindsay, R.M., Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: an overview. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 1996, 351(1338), 365-373.